Nicholas Teman
Concepts (356)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiac Surgical Procedures | 39 | 2024 | 506 | 12.000 |
Why?
| Extracorporeal Membrane Oxygenation | 17 | 2024 | 286 | 6.340 |
Why?
| Thoracic Surgery | 11 | 2025 | 123 | 5.290 |
Why?
| Coronary Artery Bypass | 10 | 2025 | 224 | 4.100 |
Why?
| Operating Rooms | 5 | 2024 | 115 | 3.170 |
Why?
| Surgeons | 10 | 2025 | 264 | 2.740 |
Why?
| Postoperative Complications | 32 | 2025 | 2477 | 2.590 |
Why?
| Pulmonary Embolism | 6 | 2024 | 212 | 2.260 |
Why?
| Heart-Assist Devices | 8 | 2024 | 537 | 2.120 |
Why?
| Intensive Care Units | 7 | 2024 | 735 | 2.100 |
Why?
| Retrospective Studies | 61 | 2025 | 14522 | 1.860 |
Why?
| Heart Valve Prosthesis Implantation | 8 | 2022 | 177 | 1.790 |
Why?
| Heart Arrest | 5 | 2024 | 320 | 1.790 |
Why?
| Airway Extubation | 3 | 2024 | 54 | 1.750 |
Why?
| Heart Transplantation | 7 | 2023 | 721 | 1.550 |
Why?
| Elective Surgical Procedures | 2 | 2024 | 164 | 1.530 |
Why?
| Cardiopulmonary Bypass | 5 | 2024 | 203 | 1.510 |
Why?
| Tricuspid Valve Insufficiency | 5 | 2020 | 24 | 1.490 |
Why?
| Treatment Outcome | 33 | 2024 | 10219 | 1.410 |
Why?
| Sternotomy | 4 | 2022 | 25 | 1.400 |
Why?
| Coronary Artery Disease | 6 | 2025 | 679 | 1.390 |
Why?
| Biomedical Research | 4 | 2025 | 640 | 1.290 |
Why?
| Humans | 104 | 2025 | 129626 | 1.210 |
Why?
| Failure to Rescue, Health Care | 2 | 2024 | 3 | 1.130 |
Why?
| Shock, Cardiogenic | 4 | 2024 | 60 | 1.120 |
Why?
| Hospital Mortality | 10 | 2024 | 848 | 1.110 |
Why?
| Internship and Residency | 7 | 2021 | 1050 | 1.080 |
Why?
| Heparin | 3 | 2023 | 254 | 1.050 |
Why?
| Clinical Competence | 6 | 2021 | 1017 | 1.020 |
Why?
| Heart Failure | 6 | 2022 | 2133 | 1.000 |
Why?
| Mitral Valve Insufficiency | 2 | 2018 | 67 | 0.980 |
Why?
| Aged | 36 | 2025 | 22061 | 0.960 |
Why?
| Education, Medical, Graduate | 3 | 2019 | 442 | 0.960 |
Why?
| Middle Aged | 41 | 2025 | 31136 | 0.960 |
Why?
| Myocardial Infarction | 3 | 2024 | 1021 | 0.950 |
Why?
| Catheters | 2 | 2016 | 66 | 0.930 |
Why?
| Advanced Cardiac Life Support | 1 | 2024 | 16 | 0.910 |
Why?
| Databases, Factual | 8 | 2024 | 1269 | 0.900 |
Why?
| Delirium | 2 | 2024 | 78 | 0.880 |
Why?
| Certification | 1 | 2024 | 94 | 0.860 |
Why?
| Hospital Costs | 3 | 2023 | 115 | 0.850 |
Why?
| Male | 53 | 2025 | 63670 | 0.820 |
Why?
| Endovascular Procedures | 2 | 2020 | 301 | 0.820 |
Why?
| National Institutes of Health (U.S.) | 2 | 2020 | 122 | 0.810 |
Why?
| Critical Care | 4 | 2023 | 551 | 0.810 |
Why?
| Prosthesis Design | 5 | 2022 | 309 | 0.800 |
Why?
| Thrombosis | 2 | 2023 | 348 | 0.790 |
Why?
| Length of Stay | 6 | 2022 | 1122 | 0.790 |
Why?
| Ventricular Dysfunction, Right | 2 | 2022 | 231 | 0.780 |
Why?
| Time Factors | 13 | 2024 | 6555 | 0.770 |
Why?
| Heart Valve Prosthesis | 3 | 2022 | 112 | 0.770 |
Why?
| Risk Factors | 20 | 2025 | 9786 | 0.770 |
Why?
| Sternum | 3 | 2023 | 25 | 0.760 |
Why?
| Subclavian Vein | 1 | 2021 | 15 | 0.760 |
Why?
| Device Removal | 2 | 2020 | 136 | 0.760 |
Why?
| Aortic Valve | 5 | 2022 | 347 | 0.740 |
Why?
| Percutaneous Coronary Intervention | 3 | 2025 | 467 | 0.730 |
Why?
| Cost-Benefit Analysis | 3 | 2022 | 569 | 0.710 |
Why?
| Registries | 6 | 2025 | 1899 | 0.700 |
Why?
| Thrombectomy | 2 | 2022 | 58 | 0.700 |
Why?
| Female | 48 | 2025 | 68734 | 0.700 |
Why?
| Ventricular Dysfunction | 1 | 2020 | 15 | 0.700 |
Why?
| Aortic Valve Stenosis | 5 | 2022 | 218 | 0.690 |
Why?
| Virginia | 6 | 2023 | 60 | 0.680 |
Why?
| Financing, Organized | 1 | 2020 | 30 | 0.680 |
Why?
| Endocarditis, Bacterial | 1 | 2020 | 42 | 0.680 |
Why?
| Ventricular Outflow Obstruction | 1 | 2020 | 40 | 0.670 |
Why?
| Endocarditis | 1 | 2020 | 38 | 0.670 |
Why?
| Catheterization, Central Venous | 1 | 2021 | 104 | 0.670 |
Why?
| Faculty, Medical | 3 | 2025 | 262 | 0.670 |
Why?
| Hemorrhage | 2 | 2024 | 680 | 0.660 |
Why?
| Education, Medical | 1 | 2023 | 251 | 0.650 |
Why?
| Costs and Cost Analysis | 1 | 2020 | 201 | 0.650 |
Why?
| Recovery of Function | 1 | 2023 | 642 | 0.650 |
Why?
| Organizational Policy | 1 | 2020 | 79 | 0.640 |
Why?
| Respiratory Insufficiency | 2 | 2020 | 313 | 0.640 |
Why?
| Machine Learning | 1 | 2024 | 443 | 0.640 |
Why?
| Purinergic P2Y Receptor Antagonists | 1 | 2020 | 66 | 0.640 |
Why?
| Hippocampus | 1 | 2024 | 873 | 0.630 |
Why?
| Thrombocytopenia | 1 | 2021 | 186 | 0.630 |
Why?
| Negative-Pressure Wound Therapy | 1 | 2019 | 21 | 0.630 |
Why?
| Electronic Mail | 1 | 2019 | 60 | 0.630 |
Why?
| Rats, Sprague-Dawley | 1 | 2024 | 2395 | 0.620 |
Why?
| Patient Transfer | 3 | 2019 | 149 | 0.620 |
Why?
| Tracheostomy | 1 | 2020 | 127 | 0.600 |
Why?
| General Surgery | 3 | 2015 | 153 | 0.600 |
Why?
| Students, Medical | 1 | 2023 | 322 | 0.600 |
Why?
| Shock, Septic | 1 | 2020 | 209 | 0.560 |
Why?
| Adult | 23 | 2024 | 35599 | 0.540 |
Why?
| Surgical Wound Infection | 2 | 2023 | 283 | 0.540 |
Why?
| Educational Measurement | 2 | 2019 | 260 | 0.540 |
Why?
| Clinical Decision-Making | 1 | 2019 | 301 | 0.540 |
Why?
| Aspirin | 1 | 2020 | 380 | 0.530 |
Why?
| Survival Rate | 8 | 2024 | 1872 | 0.530 |
Why?
| Risk Assessment | 12 | 2023 | 3262 | 0.520 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2020 | 443 | 0.500 |
Why?
| Patient Reported Outcome Measures | 1 | 2019 | 374 | 0.490 |
Why?
| Stroke | 1 | 2024 | 1071 | 0.480 |
Why?
| Lung Transplantation | 2 | 2018 | 289 | 0.480 |
Why?
| Transportation of Patients | 1 | 2015 | 50 | 0.460 |
Why?
| Extracorporeal Circulation | 1 | 2014 | 13 | 0.450 |
Why?
| Factor Analysis, Statistical | 1 | 2015 | 284 | 0.450 |
Why?
| Pulsatile Flow | 1 | 2014 | 60 | 0.440 |
Why?
| Sepsis | 1 | 2020 | 575 | 0.430 |
Why?
| Anticoagulants | 4 | 2023 | 637 | 0.420 |
Why?
| Hemodynamics | 3 | 2022 | 1090 | 0.420 |
Why?
| Reoperation | 4 | 2022 | 541 | 0.420 |
Why?
| Specialties, Surgical | 1 | 2014 | 74 | 0.420 |
Why?
| Tertiary Care Centers | 1 | 2014 | 148 | 0.420 |
Why?
| Biomarkers | 1 | 2024 | 3968 | 0.420 |
Why?
| Jugular Veins | 1 | 2013 | 40 | 0.420 |
Why?
| Education, Medical, Continuing | 1 | 2014 | 122 | 0.410 |
Why?
| Vasodilator Agents | 1 | 2015 | 326 | 0.410 |
Why?
| Aortic Aneurysm | 1 | 2013 | 65 | 0.400 |
Why?
| Internationality | 1 | 2013 | 149 | 0.400 |
Why?
| Myocardial Ischemia | 1 | 2014 | 259 | 0.390 |
Why?
| Decision Making | 1 | 2019 | 863 | 0.380 |
Why?
| Aorta, Thoracic | 1 | 2014 | 263 | 0.370 |
Why?
| Propensity Score | 3 | 2024 | 264 | 0.370 |
Why?
| Thromboembolism | 1 | 2012 | 112 | 0.370 |
Why?
| Acute Disease | 5 | 2024 | 979 | 0.360 |
Why?
| Esophagectomy | 1 | 2012 | 126 | 0.360 |
Why?
| Patient Positioning | 2 | 2021 | 53 | 0.340 |
Why?
| United States | 10 | 2025 | 13871 | 0.340 |
Why?
| Preoperative Care | 1 | 2012 | 338 | 0.330 |
Why?
| Oxygen | 1 | 2015 | 915 | 0.330 |
Why?
| Sarcopenia | 2 | 2024 | 74 | 0.330 |
Why?
| Nitric Oxide | 1 | 2015 | 895 | 0.320 |
Why?
| Cardiopulmonary Resuscitation | 2 | 2024 | 233 | 0.320 |
Why?
| Cardiologists | 2 | 2019 | 46 | 0.320 |
Why?
| Odds Ratio | 2 | 2023 | 1019 | 0.310 |
Why?
| Esophageal Neoplasms | 1 | 2012 | 297 | 0.300 |
Why?
| Transcatheter Aortic Valve Replacement | 2 | 2022 | 121 | 0.300 |
Why?
| Frailty | 2 | 2024 | 152 | 0.300 |
Why?
| Preoperative Period | 3 | 2019 | 115 | 0.290 |
Why?
| Hypoxia | 1 | 2015 | 1084 | 0.280 |
Why?
| Severity of Illness Index | 6 | 2020 | 2739 | 0.280 |
Why?
| Academic Medical Centers | 2 | 2020 | 475 | 0.270 |
Why?
| Survival Analysis | 4 | 2019 | 1269 | 0.270 |
Why?
| Bioprosthesis | 3 | 2022 | 40 | 0.260 |
Why?
| Tissue Donors | 2 | 2020 | 391 | 0.260 |
Why?
| Acute Kidney Injury | 2 | 2025 | 791 | 0.250 |
Why?
| Minimally Invasive Surgical Procedures | 3 | 2024 | 171 | 0.250 |
Why?
| Partial Thromboplastin Time | 2 | 2023 | 52 | 0.250 |
Why?
| Incidence | 5 | 2025 | 2641 | 0.250 |
Why?
| Patient Selection | 2 | 2019 | 661 | 0.250 |
Why?
| Physicians | 1 | 2014 | 866 | 0.240 |
Why?
| Michigan | 3 | 2017 | 104 | 0.240 |
Why?
| Perfusion | 2 | 2018 | 197 | 0.240 |
Why?
| Mitral Valve | 3 | 2024 | 85 | 0.240 |
Why?
| Radial Artery | 1 | 2025 | 69 | 0.230 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2024 | 41 | 0.230 |
Why?
| Blood Transfusion | 2 | 2024 | 295 | 0.220 |
Why?
| Lung Injury | 2 | 2017 | 211 | 0.220 |
Why?
| Phlebotomy | 1 | 2024 | 19 | 0.220 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2024 | 85 | 0.220 |
Why?
| Logistic Models | 4 | 2023 | 1986 | 0.220 |
Why?
| Social Class | 2 | 2023 | 259 | 0.220 |
Why?
| Random Allocation | 1 | 2024 | 347 | 0.220 |
Why?
| Factor IX | 1 | 2023 | 42 | 0.210 |
Why?
| Catheterization | 2 | 2024 | 175 | 0.210 |
Why?
| Iatrogenic Disease | 1 | 2024 | 60 | 0.210 |
Why?
| Factor VIIa | 1 | 2023 | 39 | 0.210 |
Why?
| Blood Coagulation Factors | 1 | 2023 | 53 | 0.210 |
Why?
| Renal Replacement Therapy | 1 | 2023 | 87 | 0.210 |
Why?
| Publishing | 1 | 2025 | 140 | 0.210 |
Why?
| Hospitals, Low-Volume | 1 | 2023 | 22 | 0.210 |
Why?
| Follow-Up Studies | 5 | 2019 | 4894 | 0.210 |
Why?
| Hospitals, High-Volume | 1 | 2023 | 39 | 0.210 |
Why?
| Coronary Angiography | 1 | 2025 | 306 | 0.200 |
Why?
| Disease Models, Animal | 4 | 2024 | 4078 | 0.200 |
Why?
| Prognosis | 6 | 2020 | 3774 | 0.200 |
Why?
| Acute Lung Injury | 2 | 2018 | 280 | 0.200 |
Why?
| Mentors | 2 | 2021 | 177 | 0.200 |
Why?
| Cost Savings | 1 | 2022 | 78 | 0.200 |
Why?
| Morbidity | 2 | 2020 | 302 | 0.200 |
Why?
| Pacemaker, Artificial | 2 | 2020 | 110 | 0.190 |
Why?
| Contrast Media | 1 | 2025 | 393 | 0.190 |
Why?
| Tricuspid Valve | 2 | 2022 | 27 | 0.190 |
Why?
| Schools, Medical | 1 | 2023 | 136 | 0.190 |
Why?
| Surgical Drapes | 1 | 2021 | 2 | 0.190 |
Why?
| Medical Illustration | 1 | 2021 | 9 | 0.190 |
Why?
| Kaplan-Meier Estimate | 4 | 2019 | 851 | 0.190 |
Why?
| Punctures | 1 | 2021 | 40 | 0.190 |
Why?
| Renal Insufficiency | 1 | 2023 | 150 | 0.190 |
Why?
| Bandages | 1 | 2021 | 32 | 0.190 |
Why?
| Suction | 1 | 2021 | 32 | 0.190 |
Why?
| Work-Life Balance | 1 | 2021 | 19 | 0.190 |
Why?
| Practice Guidelines as Topic | 2 | 2020 | 1501 | 0.180 |
Why?
| United Kingdom | 1 | 2022 | 257 | 0.180 |
Why?
| Interleukin-8 | 1 | 2022 | 264 | 0.180 |
Why?
| Dilatation | 1 | 2021 | 61 | 0.180 |
Why?
| Antineoplastic Agents | 1 | 2012 | 2046 | 0.180 |
Why?
| Socioeconomic Factors | 2 | 2022 | 1213 | 0.180 |
Why?
| Cohort Studies | 6 | 2020 | 5426 | 0.180 |
Why?
| Blood Coagulation | 1 | 2022 | 239 | 0.180 |
Why?
| Heart Block | 1 | 2020 | 40 | 0.170 |
Why?
| Checklist | 1 | 2021 | 93 | 0.170 |
Why?
| Vagus Nerve Injuries | 1 | 2020 | 2 | 0.170 |
Why?
| Informed Consent | 1 | 2021 | 166 | 0.170 |
Why?
| Societies, Medical | 1 | 2024 | 744 | 0.170 |
Why?
| Disinfection | 1 | 2021 | 117 | 0.170 |
Why?
| Recombinant Proteins | 1 | 2023 | 1308 | 0.170 |
Why?
| Coronary Artery Bypass, Off-Pump | 1 | 2020 | 16 | 0.170 |
Why?
| Swine | 3 | 2022 | 764 | 0.170 |
Why?
| Cardiac Catheterization | 1 | 2023 | 520 | 0.170 |
Why?
| Donor Selection | 1 | 2020 | 75 | 0.160 |
Why?
| Renal Dialysis | 1 | 2023 | 423 | 0.160 |
Why?
| Vagus Nerve | 1 | 2020 | 86 | 0.160 |
Why?
| Health Care Costs | 2 | 2020 | 367 | 0.160 |
Why?
| Teaching | 1 | 2021 | 217 | 0.160 |
Why?
| Echocardiography, Transesophageal | 1 | 2019 | 92 | 0.160 |
Why?
| Adenosine A2 Receptor Agonists | 1 | 2019 | 21 | 0.160 |
Why?
| Learning Curve | 1 | 2019 | 69 | 0.160 |
Why?
| Research Support as Topic | 1 | 2019 | 112 | 0.150 |
Why?
| Biological Products | 1 | 2022 | 205 | 0.150 |
Why?
| Lipopolysaccharides | 1 | 2022 | 877 | 0.150 |
Why?
| Warm Ischemia | 1 | 2018 | 12 | 0.150 |
Why?
| Prosthesis Fitting | 1 | 2018 | 16 | 0.150 |
Why?
| Gastrointestinal Diseases | 1 | 2020 | 198 | 0.150 |
Why?
| Psoas Muscles | 1 | 2018 | 9 | 0.150 |
Why?
| Cardiac Valve Annuloplasty | 1 | 2017 | 2 | 0.150 |
Why?
| Heart Failure, Systolic | 1 | 2018 | 25 | 0.140 |
Why?
| Sphingosine | 1 | 2018 | 40 | 0.140 |
Why?
| Protective Agents | 1 | 2018 | 39 | 0.140 |
Why?
| Coronary Disease | 1 | 2020 | 385 | 0.140 |
Why?
| Leadership | 1 | 2021 | 357 | 0.140 |
Why?
| Lysophospholipids | 1 | 2018 | 72 | 0.140 |
Why?
| Cardiac Pacing, Artificial | 1 | 2018 | 86 | 0.140 |
Why?
| Patient Readmission | 1 | 2023 | 653 | 0.140 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2019 | 127 | 0.140 |
Why?
| Workload | 2 | 2019 | 153 | 0.130 |
Why?
| Drug Therapy, Combination | 1 | 2020 | 1042 | 0.130 |
Why?
| Skin | 1 | 2021 | 727 | 0.130 |
Why?
| Reperfusion Injury | 1 | 2019 | 272 | 0.130 |
Why?
| Intubation, Intratracheal | 1 | 2018 | 242 | 0.130 |
Why?
| Stents | 1 | 2020 | 504 | 0.130 |
Why?
| Kidney Transplantation | 1 | 2023 | 670 | 0.130 |
Why?
| Kidney | 1 | 2023 | 1386 | 0.130 |
Why?
| Rats | 1 | 2024 | 5483 | 0.120 |
Why?
| Animals | 6 | 2024 | 35391 | 0.120 |
Why?
| Guideline Adherence | 1 | 2020 | 527 | 0.120 |
Why?
| Hepatectomy | 1 | 2016 | 212 | 0.120 |
Why?
| Partial Pressure | 1 | 2015 | 29 | 0.120 |
Why?
| Formative Feedback | 1 | 2015 | 26 | 0.120 |
Why?
| Patient Care Team | 1 | 2020 | 600 | 0.120 |
Why?
| Hospitals | 1 | 2020 | 637 | 0.120 |
Why?
| Comorbidity | 1 | 2020 | 1547 | 0.120 |
Why?
| Blood Gas Analysis | 1 | 2015 | 71 | 0.120 |
Why?
| Equipment Design | 1 | 2016 | 514 | 0.120 |
Why?
| Staff Development | 1 | 2015 | 55 | 0.120 |
Why?
| Analgesics, Opioid | 1 | 2022 | 913 | 0.110 |
Why?
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 1049 | 0.110 |
Why?
| Pandemics | 1 | 2023 | 1491 | 0.110 |
Why?
| Practice Patterns, Physicians' | 2 | 2020 | 1271 | 0.110 |
Why?
| Myxoma | 1 | 2014 | 12 | 0.110 |
Why?
| Heart Neoplasms | 1 | 2014 | 50 | 0.110 |
Why?
| Inflammation | 1 | 2024 | 2750 | 0.110 |
Why?
| Echocardiography, Doppler | 1 | 2014 | 108 | 0.100 |
Why?
| Administration, Inhalation | 1 | 2015 | 667 | 0.100 |
Why?
| Hemolysis | 1 | 2014 | 199 | 0.100 |
Why?
| Chemoradiotherapy, Adjuvant | 1 | 2012 | 41 | 0.100 |
Why?
| Primary Prevention | 1 | 2014 | 190 | 0.100 |
Why?
| Body Mass Index | 1 | 2020 | 2274 | 0.100 |
Why?
| Mental Disorders | 1 | 2020 | 1034 | 0.090 |
Why?
| Aorta | 1 | 2014 | 408 | 0.090 |
Why?
| Surgical Procedures, Operative | 1 | 2014 | 244 | 0.090 |
Why?
| Sheep | 1 | 2014 | 845 | 0.090 |
Why?
| Data Collection | 1 | 2014 | 650 | 0.090 |
Why?
| Recurrence | 1 | 2014 | 1011 | 0.090 |
Why?
| Respiration, Artificial | 1 | 2015 | 613 | 0.090 |
Why?
| Anti-Bacterial Agents | 1 | 2020 | 1705 | 0.090 |
Why?
| Thoracotomy | 2 | 2022 | 74 | 0.080 |
Why?
| Lung Neoplasms | 1 | 2023 | 2342 | 0.080 |
Why?
| Neoadjuvant Therapy | 1 | 2012 | 379 | 0.080 |
Why?
| Echocardiography | 3 | 2018 | 634 | 0.080 |
Why?
| Diagnosis, Differential | 1 | 2013 | 1432 | 0.080 |
Why?
| Lung | 2 | 2022 | 3938 | 0.080 |
Why?
| Myocardium | 1 | 2014 | 980 | 0.080 |
Why?
| Heart Ventricles | 1 | 2014 | 781 | 0.080 |
Why?
| Algorithms | 1 | 2015 | 1616 | 0.070 |
Why?
| Obesity | 1 | 2020 | 2882 | 0.070 |
Why?
| Blood Pressure | 1 | 2014 | 1736 | 0.070 |
Why?
| Tomography, X-Ray Computed | 1 | 2016 | 2512 | 0.070 |
Why?
| Multivariate Analysis | 2 | 2021 | 1499 | 0.070 |
Why?
| Publications | 1 | 2025 | 41 | 0.060 |
Why?
| Efficiency | 1 | 2025 | 91 | 0.060 |
Why?
| Mediastinum | 1 | 2023 | 24 | 0.050 |
Why?
| Aged, 80 and over | 3 | 2020 | 7052 | 0.050 |
Why?
| Unemployment | 1 | 2023 | 43 | 0.050 |
Why?
| Ventilators, Mechanical | 1 | 2022 | 56 | 0.050 |
Why?
| Tidal Volume | 1 | 2022 | 84 | 0.050 |
Why?
| Lymph Node Excision | 1 | 2023 | 164 | 0.050 |
Why?
| Cluster Analysis | 1 | 2023 | 482 | 0.050 |
Why?
| Surveys and Questionnaires | 1 | 2014 | 5415 | 0.050 |
Why?
| Prospective Studies | 1 | 2013 | 7135 | 0.050 |
Why?
| Antibodies | 1 | 2023 | 398 | 0.050 |
Why?
| Employment | 1 | 2023 | 167 | 0.040 |
Why?
| Travel | 1 | 2021 | 122 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2018 | 1947 | 0.040 |
Why?
| Quality Indicators, Health Care | 1 | 2023 | 298 | 0.040 |
Why?
| Quality-Adjusted Life Years | 1 | 2020 | 106 | 0.040 |
Why?
| Lymph Nodes | 1 | 2023 | 472 | 0.040 |
Why?
| Erythrocyte Transfusion | 1 | 2022 | 181 | 0.040 |
Why?
| Pain, Postoperative | 1 | 2022 | 235 | 0.040 |
Why?
| Ligands | 1 | 2022 | 621 | 0.040 |
Why?
| Toll-Like Receptor 4 | 1 | 2022 | 264 | 0.040 |
Why?
| Acetaminophen | 1 | 2022 | 247 | 0.040 |
Why?
| Pain Management | 1 | 2022 | 324 | 0.040 |
Why?
| Heart | 1 | 2023 | 641 | 0.040 |
Why?
| Neoplasm Staging | 1 | 2023 | 1282 | 0.040 |
Why?
| North Carolina | 1 | 2018 | 98 | 0.040 |
Why?
| Interleukin-6 | 1 | 2022 | 723 | 0.040 |
Why?
| Lung Abscess | 1 | 2018 | 7 | 0.040 |
Why?
| Decompressive Craniectomy | 1 | 2018 | 8 | 0.040 |
Why?
| Empyema, Pleural | 1 | 2018 | 12 | 0.040 |
Why?
| Polytetrafluoroethylene | 1 | 2018 | 24 | 0.040 |
Why?
| Organ Preservation Solutions | 1 | 2018 | 45 | 0.040 |
Why?
| Graft Survival | 1 | 2020 | 513 | 0.040 |
Why?
| Age Factors | 1 | 2025 | 3152 | 0.040 |
Why?
| Cerebral Hemorrhage | 1 | 2018 | 105 | 0.030 |
Why?
| Suture Techniques | 1 | 2018 | 118 | 0.030 |
Why?
| Death | 1 | 2018 | 117 | 0.030 |
Why?
| Educational Status | 1 | 2019 | 471 | 0.030 |
Why?
| Administration, Oral | 1 | 2019 | 787 | 0.030 |
Why?
| Observer Variation | 1 | 2018 | 314 | 0.030 |
Why?
| Organ Size | 1 | 2018 | 446 | 0.030 |
Why?
| Myocarditis | 1 | 2018 | 98 | 0.030 |
Why?
| Endothelial Cells | 1 | 2022 | 749 | 0.030 |
Why?
| Consensus | 1 | 2019 | 618 | 0.030 |
Why?
| Needs Assessment | 1 | 2018 | 357 | 0.030 |
Why?
| Cause of Death | 1 | 2017 | 395 | 0.030 |
Why?
| Atrial Fibrillation | 1 | 2019 | 376 | 0.030 |
Why?
| Vaccination | 1 | 2023 | 1347 | 0.030 |
Why?
| Stroke Volume | 1 | 2018 | 592 | 0.030 |
Why?
| Dose-Response Relationship, Drug | 1 | 2019 | 2011 | 0.030 |
Why?
| Proportional Hazards Models | 1 | 2017 | 1198 | 0.030 |
Why?
| Prevalence | 1 | 2020 | 2564 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2020 | 2720 | 0.030 |
Why?
| Curriculum | 1 | 2019 | 920 | 0.030 |
Why?
| Emergency Medical Services | 1 | 2019 | 522 | 0.030 |
Why?
| Case-Control Studies | 1 | 2020 | 3378 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2016 | 1843 | 0.020 |
Why?
| Fellowships and Scholarships | 1 | 2015 | 276 | 0.020 |
Why?
| Quality of Life | 1 | 2023 | 2688 | 0.020 |
Why?
| Child | 2 | 2022 | 20884 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2016 | 3080 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 2018 | 5455 | 0.020 |
Why?
| Hospitalization | 1 | 2016 | 2057 | 0.020 |
Why?
| Infant, Newborn | 1 | 2014 | 5756 | 0.010 |
Why?
| Magnetic Resonance Imaging | 1 | 2014 | 3394 | 0.010 |
Why?
| Mice | 1 | 2018 | 16961 | 0.010 |
Why?
| Infant | 1 | 2014 | 8995 | 0.010 |
Why?
| Child, Preschool | 1 | 2014 | 10490 | 0.010 |
Why?
| Young Adult | 1 | 2014 | 12455 | 0.010 |
Why?
| Adolescent | 1 | 2014 | 20412 | 0.010 |
Why?
|
|
Teman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|